Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study von Rueda Domínguez, A., Márquez, A., Gumá, J., Llanos, M., Herrero, J., de las Nieves, M. A., Miramón, J., Alba, E.

Volltext

Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location von Seijas-Tamayo, R., Fernández-Mateos, J., Adansa Klain, J. C., Mesía, R., Pastor Borgoñón, M., Pérez-Ruiz, E., Vázquez Fernández, S., Salvador Coloma, C., Rueda Domínguez, A., Taberna, M., Martínez-Trufero, J., Bonfill Abella, T., Vázquez Estévez, S., Pollán, M., del Barco Morillo, E., Cruz-Hernández, J. J.

Volltext

Preclinical models in head and neck squamous cell carcinoma von Chaves, Patricia, Garrido, María, Oliver, Javier, Pérez-Ruiz, Elisabeth, Barragan, Isabel, Rueda-Domínguez, Antonio

Volltext

SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma von Provencio Pulla, M., Alfaro Lizaso, J., de la Cruz Merino, L., Gumá i Padró, J., Quero Blanco, C., Gómez Codina, J., Llanos Muñoz, M., Martinez Banaclocha, N., Rodriguez Abreu, D., Rueda Domínguez, A.

Volltext

SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma von Rueda Domínguez, A., Alfaro Lizaso, J., de la Cruz Merino, L., Gumá i Padró, J., Quero Blanco, C., Gómez Codina, J., Llanos Muñoz, M., Martinez Banaclocha, N., Rodriguez Abreu, D., Provencio Pulla, M.

Volltext

CC‐99282 plus R‐CHOP in patients (pts) with previously untreated aggressive B‐cell lymphoma (a‐BCL): early safety and efficacy results from a phase 1b study von Munoz, J., Hoffmann, M., Westin, J., Vassilakopoulos, T. P., García‐Sancho, A. M., Rueda‐Domínguez, A., Jurczak, W., Kwiatek, M., Bouzani, M., Gkasiamis, A., Patel, A., Boucaud, F., Li, J., Nowakowski, G. S.

Volltext

Dynamic Exosome Analysis to Predict Response to the Combination of SABR and Immunotherapy in Oligoprogressive Disease von Martin, J. Zafra, Onieva, J.L., Roman, A., Garrido, M., Oliver, J., Martinez-Galvez, B., Dubbelman, J., Mesas, A., Villatoro, R., Ramos, I., Rueda-Dominguez, A., Perez-Ruiz, E., Benitez, J.C., Medina, J.A., Alba, E., Sett, R. Chicas, Barragan, I.

Volltext

Epigenetic targets to enhance antitumor immune response through the induction of tertiary lymphoid structures von Omotesho, Quadri Ajibola, Escamilla, Alejandro, Pérez-Ruiz, Elisabeth, Frecha, Cecilia A, Rueda-Domínguez, Antonio, Barragán, Isabel

Volltext

1481P Singular immune-related adverse events and efficacy outcomes of immune checkpoint inhibitors in advanced non-small cell lung cancer von Jurado García, J.M., Cobo Dols, M., Cantero, A., Gutierrez Calderon, V., Jiménez Gallego, P., Perez Ruiz, E., Berciano Guerrero, M.A., Montesa Pino, A., Ramos Garcia, I., Rueda Dominguez, A.

Volltext

GLOFITAMAB PLUS POLATUZUMAB VEDOTIN DEMONSTRATES DURABLE RESPONSES AND A MANAGEABLE SAFETY PROFILE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA von Hutchings, M., Avigdor, A., Sureda, A., Terol, M. J., Bosch, F., Corradini, P., Larsen, T. Stauffer, Domínguez, A. Rueda, Skarbnik, A., Jørgensen, J., Goldschmidt, N., Gurion, R., Zinzani, P. L., Pinto, A., Cordoba, R., Bottos, A., Huang, Z., Simko, S., Relf, J., Filézac de L’Etang, A., Sellam, G., Gritti, G.

Volltext

P1.21-02 Genetic Susceptibility to Immune Checkpoints Blockade Resistance von Marin, P., Onieva, J.L., Oliver, J., Garrido, M., Garcia, A., Martinez, B., Dubbelman, J.B., Mesas, A., Ramos, I., Cobo, M., Cantero, A., Gutierrez, V., Perez-Ruiz, E., Zafra, J., Rueda-Dominguez, A., Barragan, I., Benítez, J.C.

Volltext

2204P Clinical predictors and inflammatory markers for malignant pleural mesothelioma prognosis: A retrospective study in a Spanish Medical Oncology Unit von Guardamagna, M., Gonzalez, B. Villaescusa, Dolores, M.R. María, Gonzalez, E. Zamorano, Garcia, I. Ramos, Ruiz, A. Mesas, Perez, J.M. Trigo, Cantero, A., Calderon, V. Gutierrez, García, J.M. Jurado, Dominguez, A. Rueda, Mongil, R., Arrabal, R., Conejo, E. Alba, Dols, M. Cobo, Montanez, J.C. Benitez

Volltext

Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition von Guardamagna, Mora, Berciano-Guerrero, Miguel-Angel, Villaescusa-González, Beatriz, Perez-Ruiz, Elisabeth, Oliver, Javier, Lavado-Valenzuela, Rocío, Rueda-Dominguez, Antonio, Barragán, Isabel, Queipo-Ortuño, María Isabel

Volltext

187P Relationship between immune profile and immunophenotype in early breast cancer von Bravo, C.M.M., Villatoro, R., Pérez, D., Zarcos, I., Robles, L., Rodrigo, I., Pérez-Ruiz, E., Alcaide, J., Rivas-Ruiz, F., Navarro, V., Robles, M., Galeote, A., Cantizani, P., Quero, C., Dominguez, A. Rueda

Volltext

Treatment of Metastatic Melanoma at First Diagnosis: Review of the Literature von Berciano-Guerrero, Miguel-Angel, Guardamagna, Mora, Perez-Ruiz, Elisabeth, Jurado, Jose-Miguel, Barragán, Isabel, Rueda-Dominguez, Antonio

Volltext

1456P Impact of early palliative care in quality at the end of life in small cell lung cancer patients von Jiménez-García, N., Ronco-Dumas, L., Rivas-Ruiz, F., Quirós-López, R., Flores-Guardabrazo, C., Bravo, C.M.M., Jamal-Ismail Ortiz, Y., Pérez-Ruiz, E., Navarro, V., Carrasco-Zafra, M.I., Gómez, R., Domínguez, J.C., Pérez, D., Zarcos, I., Robles, M., Galeote, A., Cantizani, P., Quero, C., Rueda Dominguez, A., Villatoro, R.

Volltext

910O Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced... von Cohen, E.E., Ferris, R.L., Psyrri, A., Haddad, R., Tahara, M., Bourhis, J., Harrington, K.J., Chang, P.M-H., Lin, J-C., Razaq, M., Teixeira, M.M., Lovey, J., Chamois, J., Rueda Dominguez, A., Hu, C., Dvorkin, M., De Beukelaer, S., Pavlov, D., Thurm, H., Lee, N.

Volltext

Evolution of myeloid-derived suppressor cells and objective response rate in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL) patients after receiving immunotherapy von Cortegana, C Jiménez, Carrión, N Palazón, Fernández, E Nogales, García, M A Nieto, Margalet, V Sánchez, de la Gala, M D C Álamo, de Ilárduya, M Suengas Martínez, Burgos, E Montilla, Fernández, I Araújo, Carrasco, F Henao, García-Sancho, A Martín, Carnicero, F., Herranz, E Rios, de la Cruz Vicente, F., Fernández, R., Dominguez, A Rueda, de la Cruz Merino, L.

Volltext

1267PEvolution of myeloid-derived suppressor cells and objective response rate in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL) patients after receiving immunothera... von Cortegana, C Jiménez, Carrión, N Palazón, Fernández, E Nogales, García, M A Nieto, Margalet, V Sánchez, de la Gala, M D C Álamo, de Ilárduya, M Suengas Martínez, Burgos, E Montilla, Fernández, I Araújo, Carrasco, F Henao, García-Sancho, A Martín, Carnicero, F, Herranz, E Rios, de la Cruz Vicente, F, Fernández, R, Dominguez, A Rueda, de la Cruz Merino, L

Volltext

1267P - Evolution of myeloid-derived suppressor cells and objective response rate in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL) patients after receiving immunoth... von Cortegana, C Jiménez, Carrión, N Palazón, Fernández, E Nogales, García, M A Nieto, Margalet, V Sánchez, de la Gala, M D C Álamo, de Ilárduya, M Suengas Martínez, Burgos, E Montilla, Fernández, I Araújo, Carrasco, F Henao, García-Sancho, A Martín, Carnicero, F., Herranz, E Rios, de la Cruz Vicente, F., Fernández, R., Dominguez, A Rueda, de la Cruz Merino, L.

Volltext